1 MaxLCBI(
4mm)
was defined as the maximum LCBI within any 4-mm-long segment.
2 The cumulative failure of the
AADI was defined as intraocular pressure (IOP) >18 mm Hg or not re
3 Metabolic
adaptation was defined as a significantly different (lower or higher) me
4 Conduction delay (
CD)
was defined as interelectrode conduction time of 7 to 11 ms a
5 CHD was defined as >=1 inpatient code or >=2 outpatient CHD diagn
6 rall (three stakeholder groups combined) results,
consensus was defined as outcomes scoring greater than 90% "critical" a
7 Failure to
cure was defined as: 1) no surgical resection due to intraoperativ
8 DAT
deficit was defined as less than 65% of putamen striatal binding rati
9 The date of
diagnosis was defined as the index date.
10 Efficacy was defined as complete response (CR) rate on end-of-treatmen
11 Treatment
failure was defined as (1) any further surgical procedure related to
12 Vaccine
failure was defined as TBE despite adherence to the recommended vacci
13 A true-positive
finding was defined as the presence of a pathology-confirmed cancer w
14 Metabolic
flexibility was defined as the change in 24-h RQ from EBL during fasting
15 Frailty was defined as having >=3 of the following 5 criteria from th
16 Refractory
glaucoma was defined as IOP >21 mmHg on maximum tolerated glaucoma med
17 Hypertension was defined as prescription of blood pressure-lowering drugs
18 Cognitive
impairment was defined as the lowest tertile in the main analysis and as
19 Clinically relevant CMV
infection was defined as either plasma CMV DNAemia >= 1000 IU/mL with/w
20 NPV) and positive predictive value (PPV) occurred when
iPET was defined as positive if the Deauville score was 4-5 (89% a
21 A chronic or resolved PAMM
lesion was defined as inner nuclear layer thinning with outer plexif
22 Incident visual
loss was defined as the development of or worsening of visual loss
23 Lymphedema was defined as a >= 10% relative increase in arm volume arisi
24 Relapse of
ME was defined as increase in macular thickness to >=240 mum in
25 MM was defined as at least 3 coexistent morbidities of high bloo
26 Noninferiority was defined as the lower limit of the 95% CI for the differen
27 Recipient
obesity was defined as body mass index (BMI) >35 adjusted for ascites
28 Airway
obstruction was defined as forced expiratory volume in 1-second (FEV1)/fo
29 Adverse
outcome was defined as intensive care unit (ICU) admission or death.
30 Favourable functional
outcome was defined as a modified Rankin Scale score of 0-2 or a Glas
31 Poor
outcome was defined as invasive ventilation and/or death.
32 Unfavourable
outcome was defined as death or significant grey matter injury on MRI
33 Short-term variability during a particular
period was defined as the variability in IOP measurements obtained d
34 POAF was defined as occurrence of postcardiac surgery atrial fibri
35 For this study, lead
poisoning was defined as a blood lead level (BLL) greater than or equal
36 The
PPV was defined as the proportion of patients who had true-positi
37 Proteinuria was defined as Delta urine protein >=300 mg/24 h at 1 year af
38 Tumor
recurrence was defined as biopsy-proven vital tumor at the initial tumor
39 Relapse was defined as new or reappearing symptoms or worsening disea
40 Maintenance of
remission was defined as absence of clinical and histologic relapse and
41 Failure of
SLT was defined as any further glaucoma procedure post-SLT or any
42 SR was defined as modified thrombolysis in cerebral ischemia 2b
43 Success was defined as improvement in 3 Early Treatment Diabetic Reti
44 Anatomical
success was defined as the maintenance of retinal reattachment withou
45 Treatment
success was defined as rCDI prevention through 8 weeks after treatmen
46 TC was defined as same-nodule histologic malignancy.
47 Hypercoagulable
thromboelastography was defined as two or more hypercoagulable parameters.
48 Symptomatic venous
thromboembolism was defined as deep vein thrombosis, pulmonary embolism, or b
49 Worsening traction after
treatment was defined as the occurrence within 6 months of worsening or
50 viral load in the year preceding elicitation, and
viraemia was defined as a viral load of 200 copies per mL or more.